145 related articles for article (PubMed ID: 12405438)
1. Malignant pleural mesothelioma in a child: long-term survival with ICE-WAC chemotherapy regimen.
Mutafoğlu-Uysal K; Kargi A; Sarialioğlu F; Olgun N; Kovanlikaya A
Turk J Pediatr; 2002; 44(3):244-7. PubMed ID: 12405438
[TBL] [Abstract][Full Text] [Related]
2. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.
Hagemeister FB
Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S13-20. PubMed ID: 12042984
[TBL] [Abstract][Full Text] [Related]
3. [A case of sarcomatoid malignant peritoneal mesothelioma responding to combination chemotherapy of cyclophosphamide, vincristine, adriamycin and dacarbazine(CYVADIC)].
Kusama T; Kodaka T; Tsunemine H; Akasaka H; Koizumi N; Fujimoto K; Sakano S; Ito R; Kondo T; Kitazawa S; Yamamura H; Takahashi K
Gan To Kagaku Ryoho; 2009 Mar; 36(3):475-8. PubMed ID: 19295275
[TBL] [Abstract][Full Text] [Related]
4. Outcome of pediatric recurrent and refractory malignant solid tumors following ifosfamide/carboplatin/etoposide (ICE): A phase II study in a pediatric oncology centre in Brazil.
Loss JF; Santos PP; Leone LD; Brunetto AL
Pediatr Blood Cancer; 2004 Feb; 42(2):139-44. PubMed ID: 14752877
[TBL] [Abstract][Full Text] [Related]
5. Treatment of metastatic rhabdoid tumor of the kidney.
Wagner L; Hill DA; Fuller C; Pedrosa M; Bhakta M; Perry A; Dome JS
J Pediatr Hematol Oncol; 2002; 24(5):385-8. PubMed ID: 12142788
[TBL] [Abstract][Full Text] [Related]
6. [A diffuse, pleural, malignant mesothelioma kept in long remission by chemotherapy combining pirarubicin and cisplatin].
Niki Y; Soga T; Nishimura A; Kato M; Hamada M; Kanamaru M
Gan No Rinsho; 1990 Nov; 36(14):2463-7. PubMed ID: 2250368
[TBL] [Abstract][Full Text] [Related]
7. Ifosfamide, carboplatin and etoposide combined with 41.8 degrees C whole body hyperthermia for malignant pleural mesothelioma.
Bakhshandeh A; Bruns I; Traynor A; Robins HI; Eberhardt K; Demedts A; Kaukel E; Koschel G; Gatzemeier U; Kohlmann T; Dalhoff K; Ehlers EM; Gruber Y; Zumschlinge R; Hegewisch-Becker S; Peters SO; Wiedemann GJ
Lung Cancer; 2003 Mar; 39(3):339-45. PubMed ID: 12609573
[TBL] [Abstract][Full Text] [Related]
8. [Neoadjuvant treatment of Ewing's sarcoma: results obtained in 122 patients treated with a 6-drug chemotherapeutic protocol (vincristine, adriamycin, cyclophosphamide, dactinomycin, ifosfamide and etoposide)].
Bacci G; Ferrari S; Rosito P; Barbieri E; Mercuri M; Brach del Prever A; Iantorno D; Forni C; Campanacci M
Minerva Pediatr; 1995 Nov; 47(11):457-69. PubMed ID: 8684341
[TBL] [Abstract][Full Text] [Related]
9. Desmoplastic small round-cell tumor: prolonged progression-free survival with aggressive multimodality therapy.
Kushner BH; LaQuaglia MP; Wollner N; Meyers PA; Lindsley KL; Ghavimi F; Merchant TE; Boulad F; Cheung NK; Bonilla MA; Crouch G; Kelleher JF; Steinherz PG; Gerald WL
J Clin Oncol; 1996 May; 14(5):1526-31. PubMed ID: 8622067
[TBL] [Abstract][Full Text] [Related]
10. All children with malignant rhabdoid tumors should be treated initially with intensive chemotherapy.
Hernández-Marqués C; Lassaletta A; Cormenzana M; García-Esparza E; Madero-López L
Pediatr Hematol Oncol; 2015 Apr; 32(3):193-8. PubMed ID: 24852450
[TBL] [Abstract][Full Text] [Related]
11. Refining therapeutic strategies for patients with resistant Wilm's tumor.
Marina NM; Wilimas JA; Meyer WH; Jones DP; Douglass EC; Pratt CB
Am J Pediatr Hematol Oncol; 1994 Nov; 16(4):296-300. PubMed ID: 7978044
[TBL] [Abstract][Full Text] [Related]
12. Addition of ifosfamide and etoposide to standard chemotherapy for Ewing's sarcoma and primitive neuroectodermal tumor of bone.
Grier HE; Krailo MD; Tarbell NJ; Link MP; Fryer CJ; Pritchard DJ; Gebhardt MC; Dickman PS; Perlman EJ; Meyers PA; Donaldson SS; Moore S; Rausen AR; Vietti TJ; Miser JS
N Engl J Med; 2003 Feb; 348(8):694-701. PubMed ID: 12594313
[TBL] [Abstract][Full Text] [Related]
13. [Primary rhabdomyosarcoma of the temporal bone].
Lorenzo Núñez R; Ramos Benavente MD; Morales Jiménez C; Ruiz Medina E
Acta Otorrinolaringol Esp; 1995; 46(1):53-6. PubMed ID: 7734166
[TBL] [Abstract][Full Text] [Related]
14. Complete response and long-term survival in malignant pleural mesothelioma: case report.
Takanen S; Resuli B; Graziano V; Parisi A; Lisi R; Raffetto N; Tombolini V
Anticancer Res; 2012 Apr; 32(4):1485-7. PubMed ID: 22493390
[TBL] [Abstract][Full Text] [Related]
15. A case of repetitive intrapleural cancer chemotherapy using INFUSE-A-PORT for malignant mesothelioma.
Omasa M; Hirata T; Shoji T; Bando T; Hasegawa S; Inui K; Wada H
Thorac Cardiovasc Surg; 2001 Aug; 49(4):233-5. PubMed ID: 11505321
[TBL] [Abstract][Full Text] [Related]
16. Chemotherapy of malignant diffuse mesothelioma.
Kucuksu N; Thomas W; Ezdinli EZ
Cancer; 1976 Mar; 37(3):1265-74. PubMed ID: 1260651
[TBL] [Abstract][Full Text] [Related]
17. Cure in a case of primary hepatic lymphoma.
Murthy SA; Singh B; Bhalla S; Arora A; Vohra R; Aggarwal S
Indian J Cancer; 2000 Dec; 37(4):165-72. PubMed ID: 12018569
[TBL] [Abstract][Full Text] [Related]
18. [Evaluation of the therapeutic benefit of 41.8 degrees C whole body hyperthermia plus ifosfamide, carboplatin and etoposide (ICE) for patients with malignant pleural mesothelioma using the Modified Brunner-Score (MBS)].
Bruns I; Kohlmann T; Wiedemann GJ; Bakhshandeh A
Pneumologie; 2004 Apr; 58(4):210-6. PubMed ID: 15098157
[TBL] [Abstract][Full Text] [Related]
19. Chemotherapy for malignant mesothelioma; CAMEO.
Jett JR; Eagan RT
Am J Clin Oncol; 1982 Aug; 5(4):429-31. PubMed ID: 7051806
[TBL] [Abstract][Full Text] [Related]
20. Ifosfamide, carboplatin and etoposide (ICE) as second-line regimen alone and in combination with regional hyperthermia is active in chemo-pre-treated advanced soft tissue sarcoma of adults.
Fiegl M; Schlemmer M; Wendtner CM; Abdel-Rahman S; Fahn W; Issels RD
Int J Hyperthermia; 2004 Sep; 20(6):661-70. PubMed ID: 15370821
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
